Metyrapone in the therapy of vitiligo
Dolecek, R.
Casopis Lekaru Ceskych 122(18): 564-567
1983
ISSN/ISBN: 0008-7335 PMID: 6850733 Document Number: 213193
Document emailed within 1 workday
Related Documents
Rogóz, Z.; Skuza, G.; Wójcikowski, J.; Daniel, Władysława.A.; Wróbel, A.; Dudek, D.; Zieba, A. 2004: Effect of metyrapone supplementation on imipramine therapy in patients with treatment-resistant unipolar depression Polish Journal of Pharmacology 56(6): 849-855Arroyo, M.P.; Tift, L. 2003: Vitiligo therapy: where are we now? Journal of Drugs in Dermatology: Jdd 2(4): 404-408
Gokhale, B.B. 1979: Intermittent Therapy with Corticotrophin in Vitiligo Indian Journal of Dermatology Venereology and Leprology 45(3): 195-202
Picardi, A.; Abeni, D. 2001: Can cognitive-behavioral therapy help patients with vitiligo? Archives of Dermatology 137(6): 786-788
Rzepecki, A.K.; McLellan, B.N.; Elbuluk, N. 2018: Beyond Traditional Treatment: the Importance of Psychosocial Therapy in Vitiligo Journal of Drugs in Dermatology: Jdd 17(6): 688-691
Jansen, T.; Megahed, M.; Hölzle, E.; Plewig, G. 1995: Provocation of porphyria cutanea tarda by KUVA-therapy of vitiligo Acta Dermato-Venereologica 75(3): 232-233
Serrano, G.; Lorente, M.; Reyes, M.; Millán, F.; Lloret, A.án.; Melendez, J.ín.; Navarro, M.; Navarro, M. 2009: Photodynamic therapy with low-strength ALA, repeated applications and short contact periods (40-60 minutes) in acne, photoaging and vitiligo Journal of Drugs in Dermatology: Jdd 8(6): 562-568
Selye, H.; Mécs, I. 1970: Blockade of catatoxic steroid actions by metyrapone Acta Physiologica Academiae Scientiarum Hungaricae 37(1): 141-144
De Graeve, J.; Gielen, J.E.; Kahl, G.F.; Tüttenberg, K.H.; Kahl, R.; Maume, B. 1979: Formation of two metyrapone N-oxides by rat liver microsomes Drug Metabolism and Disposition: the Biological Fate of Chemicals 7(3): 166-170
Galinsky, R.E.; Corcoran, G.B. 1988: Suppression of acetaminophen conjugation and of conjugate elimination in the rat by metyrapone, a classical P-450 inhibitor Drug Metabolism and Disposition: the Biological Fate of Chemicals 16(3): 348-354
Daley, C.A.; Zerbe, C.A.; Schick, R.O.; Powers, R.D. 1993: Use of metyrapone to treat pituitary-dependent hyperadrenocorticism in a cat with large cutaneous wounds Journal of the American Veterinary Medical Association 202(6): 956-960
Imamura, Y.; Murata, H.; Otagiri, M. 1993: Postnatal development and sex-related difference of metyrapone reductase activities in liver microsomes and cytosol of the rat Research Communications in Chemical Pathology and Pharmacology 82(1): 101-110
Shaw, P.N.; Tseti, J.; Warburton, S.; Adedoyin, A.; Houston, J.B. 1986: Inhibition of antipyrine metabolite formation. Steady state studies with cimetidine and metyrapone in rats Drug Metabolism and Disposition: the Biological Fate of Chemicals 14(2): 271-276
Angeli, A.; Fonzo, D.; Bertello, P.; Gaidano, G.; Ceresa, F. 1975: Circadian rhythm of urinary 17-hydroxycorticosteroids during metyrapone-induced ACTH release in normal subjects Chronobiologia 2(2): 133-144
Zgliczyński, S.; Kozłowicz, I.; Wilczyńska, J.; Baranowska, B. 1980: Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report Materia Medica Polona. Polish Journal of Medicine and Pharmacy 12(1-2): 85-90
Rossi, M.A.; Chervin, R.A.; Bruno, O.D. 1996: Night suppression with high doses of dexamethasone and metyrapone tests for the etiological diagnosis of Cushing syndrome Medicina 56(5 Part 1): 455-462
Balestreri, R.; Jacopino, G.E.; Barreca, T.; Cicchetti, V. 1974: Study of the pituitary corticotropin reserve with metyrapone in subjects treated with a steroid association and with the single components Folia Endocrinologica 27(2): 168-178
Dal Pra, P.; Melosi, P.; Rossini, L. 1972: Ethanol and metyrapone effect on the redox potential, its compartimentalization, and its relation to the high energy phosphates of the rat liver in vivo Archives Internationales de Pharmacodynamie et de Therapie 196: Suppl 196: 162
Konishi, Y. 1981: Effects of tamoxifen, stilbestrol and metyrapone on binding of various steroids to cytosol receptors in human breast cancer cytosols Kobe Journal of Medical Sciences 27(3): 103-112
Lamberts, S.W.; Bons, E.G.; Bruining, H.A.; de Jong, F.H. 1987: Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells Journal of Pharmacology and Experimental Therapeutics 240(1): 259-264